Interview, Fireside Chat
7 More Healthy Years: What We Can Learn from Super Agers
- The healthcare system is anticipated to undergo a "reboot" focused on the intelligent partitioning of risk to prevent the "big three" age-related diseases (cancer, cardiovascular disease, neurodegenerative disease), with a projected outcome of adding "seven years more of healthspan."
- Investments in reversing aging are predicted to continue despite current evidence being limited to rodents, while the broader medical shift is expected to prioritize prevention of age-related diseases using new aging metrics and data layers.
- Prevention via lifestyle and modifiable factors is projected to address cardiovascular disease in "80% and 90%" of cases, while cancer and neurodegenerative diseases are expected to be preventable in "about half" of cases through current knowledge, though lifestyle alone will be insufficient due to environmental burdens like plastics and air pollution.
- Multimodal AI and large reasoning models are expected to integrate vast individual data to predict health trajectories with "99% confidence," utilizing baseline data up to 25 years to forecast specific outcomes.
- Specific predictive capabilities are expected to identify timelines for conditions like mild cognitive impairment, such as "18 years from now, 12 years, four years," based on metrics like P tau 217, which may provide "over a 20-year warning."
- Immune system modulation via cell therapies is expected to improve to potentially cure cancer or treat autoimmune diseases, while personalized vaccines aim to prevent cancer by addressing senescent and weak immune systems.
- Future drug applications are expected to enable the treatment and prevention of addiction by leveraging understanding of the gut-brain axis, while GLP-1 drugs and their successors are anticipated to be widely used, even in non-overweight populations for Alzheimer's prevention, potentially substituting for injections with fewer side effects.
- While patients may be able to "go off the drugs at least for some periods of time and not rebound," current data is not yet encouraging, though combining these drugs with strength training is expected to mitigate muscle mass loss.
- Organ clocks for the brain, heart, and immune system are expected to integrate with polygenic risk scores and epigenetic data to identify specific organ risks, replacing mass screening programs with risk-profile-based screening to "save a tremendous amount of money."
- Implementation is expected to occur gradually over the "next five to ten years," with other countries likely adopting these strategies more readily than the US due to fewer obstacles, ultimately bending the curve toward older and healthier populations.
- The opportunity to implement this preventive path is described as unique, with the potential to prevent loss of life from cancer and extend healthspan, though a single protein test for P tau 217 remains a key modifiable intervention for cognitive impairment.